Figures & data
![Figure 1 Continuum from exposure to disease. Adapted from NRC(Citation9) and Schulte and Perera.(Citation10). Reproduced from Environmental Health Perspectives.](/cms/asset/a5a3a1e5-6ddd-4c4d-b9c8-fdaa2012c153/uoeh_a_1060324_f0001_b.gif)
Table 1 Glossary of Key Terms
Table NaN Glossary of Key Terms (Continued)
Table 2 Definitions of Acronyms
Table 3 Efforts Affecting the Use of 21st Century Technologies and Risk Assessment
![Figure 2 Biologic responses as a result of an exposure. The intersection results in perturbation of biologic pathways. When perturbations are sufficiently large or when the host is unable to adapt because of underlying nutritional, genetic, disease, or life-stage status, biologic function is compromised, and this leads to toxicity and disease.(Citation94) © Elsevier. Reproduced by permission of Elsvier. Permission to reuse must be obtained from the rightsholder.](/cms/asset/3393a115-c5fd-402d-a90f-ffe1f8f51891/uoeh_a_1060324_f0002_b.gif)
Table 4 Different Types of Biomarkers
Table 5 Examples of -Omics Technologies
Table 6 Uses of Biomarkers in Hazard Characterization and Dose-Response Analysis
![Figure 3 Frequency distribution of a biomarker (physiological parameter) in two hypothetical populations to illustrate the effect of exposure and susceptibility factors. Adapted from Woodruff et al.(Citation95). Reproduced from Environmental Health Perspectives.](/cms/asset/b7454df2-70c3-4c92-a730-b5d229139281/uoeh_a_1060324_f0003_b.gif)